(Q37889152)

24 August 2017

1 reference

title

Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules (English)

1 reference

24 August 2017

1 reference

1 reference

1 reference

Peter Loewen

1

1 reference

24 August 2017

Karen Dahri

series ordinal

2

1 reference

24 August 2017

language of work or name

1 reference

14 June 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

90

1 reference

24 August 2017

issue

10

1 reference

24 August 2017

page(s)

1191-1200

1 reference

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Searching for clinical prediction rules in MEDLINE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Users' Guides to the Medical Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Integrating stratum-specific likelihood ratios with the analysis of ROC curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Diagnostic tests 4: likelihood ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

How to read a paper. Papers that report diagnostic or screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Use and misuse of the receiver operating characteristic curve in risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Usefulness of outpatient bleeding risk index to predict bleeding complications in patients with long-term oral anticoagulation undergoing coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Bleeding Risk Index in an anticoagulation clinic. Assessment by indication and implications for care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Validation of Clinical Classification Schemes for Predicting Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Risk stratification and therapeutic decision making in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Evaluating the yield of medical tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1267-3

10.1007/S00277-011-1267-3

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference